Skip to main content
Top
Published in: Clinical Rheumatology 1/2019

01-01-2019 | Brief Report

Hypertrophic osteoarthropathy: estrogens, prostaglandinE2, prostaglandin A2, and the inflammatory reflex

Authors: Ad Brouwers, Pieter G. Dingjan, Ben Dujardin, Everardus J. van Zoelen, Paul Lips, Louis J. Gooren

Published in: Clinical Rheumatology | Issue 1/2019

Login to get access

Abstract

It has been claimed that hyperestrogenism occurs in hypertrophic osteoarthropathy (HOA), but not in simple clubbing. However, one of our patients had simple clubbing and hyperestrogenism. We therefore measured estrogens, androgens, sex hormone-binding globulin (SHBG), and gonadotropins in five patients with HOA and in 18 patients with simple clubbing. Of the patients with HOA, 80% had a high urinary estriol concentration. In their serum, 80% had high estrone, 0% high estradiol, and 40% high SHBG. Of the patients with simple clubbing, 89% had a high urinary estriol concentration. In their serum, 76% had high estrone, 6% high estradiol, and 31% high SHBG. In all patients, urinary estriol concentration correlated positively with the degree of clubbing. Serum concentration of androstenedione, testosterone, luteinizing hormone (LH), and follicle-stimulating hormone (FSH) was mostly normal, but androstenedione concentration correlated positively with the degree of clubbing. Spider angiomas were present in 74%, palmar erythema in 39%, and gynecomastia in 9%. Urinary creatinine concentration was low in 48% and correlated positively with the degree of clubbing. We reject the claim that hyperestrogenism occurs in HOA, but not in simple clubbing. Hyperestrogenism occurs both in HOA and in simple clubbing. Our results also support earlier reports that clubbing and HOA are associated with spider angiomas, palmar erythema, gynecomastia, adrenal cortical hyperfunction, muscle atrophy, and water retention. These results led to a new hypothesis on the pathogenesis of HOA, involving estrogens, prostaglandin E2, prostaglandin A2, and the inflammatory reflex.
Literature
2.
go back to reference Ginsburg J, Brown JB (1961) Increased oestrogen excretion in hypertrophic pulmonary osteoarthropathy. Lancet 2:1274–1276CrossRefPubMed Ginsburg J, Brown JB (1961) Increased oestrogen excretion in hypertrophic pulmonary osteoarthropathy. Lancet 2:1274–1276CrossRefPubMed
3.
go back to reference Lubowski D (1984) Increased oestrogen production and adrenal cortical hyperfunction in patients with pulmonary disease and clubbing of the fingers. S Afr Med J 66:57–58PubMed Lubowski D (1984) Increased oestrogen production and adrenal cortical hyperfunction in patients with pulmonary disease and clubbing of the fingers. S Afr Med J 66:57–58PubMed
5.
go back to reference Waring WW, Wilkinson RW, Wiebe RA, Faul BC, Hilman BC (1971) Quantitation of digital clubbing in children. Measurements of casts of the index finger. Am Rev Respir Dis 104:166–174PubMed Waring WW, Wilkinson RW, Wiebe RA, Faul BC, Hilman BC (1971) Quantitation of digital clubbing in children. Measurements of casts of the index finger. Am Rev Respir Dis 104:166–174PubMed
6.
go back to reference Gebhardt DO, Soederhuizen W, Moolenaar AJ (1985) Use of octadecyl (C18) columns for the estimation of oestrogens in the urine of non-pregnant women. Ann Clin Biochem 22:541–543CrossRefPubMed Gebhardt DO, Soederhuizen W, Moolenaar AJ (1985) Use of octadecyl (C18) columns for the estimation of oestrogens in the urine of non-pregnant women. Ann Clin Biochem 22:541–543CrossRefPubMed
7.
go back to reference Zhang Z, Zhang C, Zhang Z (2013) Primary hypertrophic osteoarthropathy: an update. Front Med 7:60–64CrossRefPubMed Zhang Z, Zhang C, Zhang Z (2013) Primary hypertrophic osteoarthropathy: an update. Front Med 7:60–64CrossRefPubMed
8.
go back to reference Uppal S, Diggle CP, Carr IM, Fishwick CW, Ahmed M, Ibrahim GH, Helliwell PS, Latos-Bieleńska A, Phillips SE, Markham AF, Bennett CP, Bonthron DT (2008) Mutations in 15-hydroxyprostaglandin dehydrogenase cause primary hypertrophic osteoarthropathy. Nat Genet 40:789–793CrossRefPubMed Uppal S, Diggle CP, Carr IM, Fishwick CW, Ahmed M, Ibrahim GH, Helliwell PS, Latos-Bieleńska A, Phillips SE, Markham AF, Bennett CP, Bonthron DT (2008) Mutations in 15-hydroxyprostaglandin dehydrogenase cause primary hypertrophic osteoarthropathy. Nat Genet 40:789–793CrossRefPubMed
9.
go back to reference Murphey LJ, Williams MK, Sanchez SC, Byrne LM, Csiki I, Oates JA, Johnson DH, Morrow JD (2004) Quantification of the major urinary metabolite of PGE2 by a liquid chromatographic/mass spectrometric assay: determination of cyclooxygenase-specific PGE2 synthesis in healthy humans and those with lung cancer. Anal Biochem 334:266–275CrossRefPubMed Murphey LJ, Williams MK, Sanchez SC, Byrne LM, Csiki I, Oates JA, Johnson DH, Morrow JD (2004) Quantification of the major urinary metabolite of PGE2 by a liquid chromatographic/mass spectrometric assay: determination of cyclooxygenase-specific PGE2 synthesis in healthy humans and those with lung cancer. Anal Biochem 334:266–275CrossRefPubMed
10.
go back to reference Cattral MS, Altraif I, Greig PD, Blendis L, Levy GA (1994) Toxic effects of intravenous and oral prostaglandin E therapy in patients with liver disease. Am J Med 97:369–373CrossRefPubMed Cattral MS, Altraif I, Greig PD, Blendis L, Levy GA (1994) Toxic effects of intravenous and oral prostaglandin E therapy in patients with liver disease. Am J Med 97:369–373CrossRefPubMed
11.
go back to reference Lund J, Brown WP, Tregerman L (1982) The toxicology of PGE1 and PGI2. In: Wu K, Rossi EC (eds) Prostaglandins in clinical medicine and thrombotic disorders. Year Book Medical Publishers, Inc, Chicago, pp 93–109 Lund J, Brown WP, Tregerman L (1982) The toxicology of PGE1 and PGI2. In: Wu K, Rossi EC (eds) Prostaglandins in clinical medicine and thrombotic disorders. Year Book Medical Publishers, Inc, Chicago, pp 93–109
12.
go back to reference High WB (1987) Effects of orally administered prostaglandin E-2 on cortical bone turnover in adult dogs: a histomorphometric study. Bone 8:363–373CrossRefPubMed High WB (1987) Effects of orally administered prostaglandin E-2 on cortical bone turnover in adult dogs: a histomorphometric study. Bone 8:363–373CrossRefPubMed
13.
go back to reference Zimna A, Kurpisz M (2015) Hypoxia-inducible Factor-1 in physiological and pathophysiological angiogenesis: applications and therapies. Biomed Res Int 549412 Zimna A, Kurpisz M (2015) Hypoxia-inducible Factor-1 in physiological and pathophysiological angiogenesis: applications and therapies. Biomed Res Int 549412
14.
go back to reference Atkinson S, Fox SB (2004) Vascular endothelial growth factor (VEGF)-A and platelet-derived growth factor (PDGF) play a central role in the pathogenesis of digital clubbing. J Pathol 203:721–728CrossRefPubMed Atkinson S, Fox SB (2004) Vascular endothelial growth factor (VEGF)-A and platelet-derived growth factor (PDGF) play a central role in the pathogenesis of digital clubbing. J Pathol 203:721–728CrossRefPubMed
15.
go back to reference Samarajeewa NU, Yang F, Docanto MM, Sakurai M, McNamara KM, Sasano H, Fox SB, Simpson ER, Brown KA (2013) HIF-1alpha stimulates aromatase expression driven by prostaglandin E2 in breast adipose stroma. Breast Cancer Res 15:R30CrossRefPubMedCentralPubMed Samarajeewa NU, Yang F, Docanto MM, Sakurai M, McNamara KM, Sasano H, Fox SB, Simpson ER, Brown KA (2013) HIF-1alpha stimulates aromatase expression driven by prostaglandin E2 in breast adipose stroma. Breast Cancer Res 15:R30CrossRefPubMedCentralPubMed
16.
go back to reference Thorsen K, Kristoffersson AO, Lerner UH, Lorentzon RP (1996) In situ microdialysis in bone tissue. Stimulation of prostaglandin E2 release by weight-bearing mechanical loading. J Clin Invest 98:2446–2449CrossRefPubMedCentralPubMed Thorsen K, Kristoffersson AO, Lerner UH, Lorentzon RP (1996) In situ microdialysis in bone tissue. Stimulation of prostaglandin E2 release by weight-bearing mechanical loading. J Clin Invest 98:2446–2449CrossRefPubMedCentralPubMed
17.
go back to reference Still K, Grabowski P, Mackie I, Perry M, Bishop N (2008) The peroxisome proliferator activator receptor alpha/delta agonists linoleic acid and bezafibrate upregulate osteoblast differentiation and induce periosteal bone formation in vivo. Calcif Tissue Int 83:285–292CrossRefPubMed Still K, Grabowski P, Mackie I, Perry M, Bishop N (2008) The peroxisome proliferator activator receptor alpha/delta agonists linoleic acid and bezafibrate upregulate osteoblast differentiation and induce periosteal bone formation in vivo. Calcif Tissue Int 83:285–292CrossRefPubMed
18.
go back to reference Straus DS, Glass CK (2001) Cyclopentenone prostaglandins: new insights on biological activities and cellular targets. Med Res Rev 21:185–210CrossRefPubMed Straus DS, Glass CK (2001) Cyclopentenone prostaglandins: new insights on biological activities and cellular targets. Med Res Rev 21:185–210CrossRefPubMed
20.
go back to reference Takahashi HK, Iwagaki H, Hamano R, Yoshino T, Tanaka N, Nishibori M (2006) Effect of nicotine on IL-18-initiated immune response in human monocytes. J Leukoc Biol 80:1388–1394CrossRefPubMed Takahashi HK, Iwagaki H, Hamano R, Yoshino T, Tanaka N, Nishibori M (2006) Effect of nicotine on IL-18-initiated immune response in human monocytes. J Leukoc Biol 80:1388–1394CrossRefPubMed
21.
go back to reference Ek M, Kurosawa M, Lundeberg T, Ericsson A (1998) Activation of vagal afferents after intravenous injection of interleukin-1beta: role of endogenous prostaglandins. J Neurosci 18:9471–9479CrossRef Ek M, Kurosawa M, Lundeberg T, Ericsson A (1998) Activation of vagal afferents after intravenous injection of interleukin-1beta: role of endogenous prostaglandins. J Neurosci 18:9471–9479CrossRef
22.
go back to reference Dam WH, Hagelsten JO (1964) Blocking of the vagus nerve relieving osteoarthropathy in lung diseases. Dan Med Bull 11:131–133PubMed Dam WH, Hagelsten JO (1964) Blocking of the vagus nerve relieving osteoarthropathy in lung diseases. Dan Med Bull 11:131–133PubMed
23.
go back to reference Huckstep RL, Bodkin PE (1958) Vagotomy in hypertrophic pulmonary osteoarthropathy associated with bronchial carcinoma. Lancet 2:343–345CrossRefPubMed Huckstep RL, Bodkin PE (1958) Vagotomy in hypertrophic pulmonary osteoarthropathy associated with bronchial carcinoma. Lancet 2:343–345CrossRefPubMed
24.
go back to reference Lopez-Enriquez E, Morales AR, Robert F (1980) Effect of atropine sulfate in pulmonary hypertrophic osteoarthropathy. Arthritis Rheum 1980;23(7):822–824 Lopez-Enriquez E, Morales AR, Robert F (1980) Effect of atropine sulfate in pulmonary hypertrophic osteoarthropathy. Arthritis Rheum 1980;23(7):822–824
25.
go back to reference Huston JM, Ochani M, Rosas-Ballina M, Liao H, Ochani K, Pavlov VA, Gallowitsch-Puerta M, Ashok M, Czura CJ, Foxwell B, Tracey KJ, Ulloa L (2006) Splenectomy inactivates the cholinergic antiinflammatory pathway during lethal endotoxemia and polymicrobial sepsis. J Exp Med 203:1623–1628CrossRefPubMedCentralPubMed Huston JM, Ochani M, Rosas-Ballina M, Liao H, Ochani K, Pavlov VA, Gallowitsch-Puerta M, Ashok M, Czura CJ, Foxwell B, Tracey KJ, Ulloa L (2006) Splenectomy inactivates the cholinergic antiinflammatory pathway during lethal endotoxemia and polymicrobial sepsis. J Exp Med 203:1623–1628CrossRefPubMedCentralPubMed
26.
go back to reference Critchley HO, Osei J, Henderson TA, Boswell L, Sales KJ, Jabbour HN, Hirani N (2006) Hypoxia-inducible factor-1alpha expression in human endometrium and its regulation by prostaglandin E-series prostanoid receptor 2 (EP2). Endocrinology 147:744–753CrossRefPubMed Critchley HO, Osei J, Henderson TA, Boswell L, Sales KJ, Jabbour HN, Hirani N (2006) Hypoxia-inducible factor-1alpha expression in human endometrium and its regulation by prostaglandin E-series prostanoid receptor 2 (EP2). Endocrinology 147:744–753CrossRefPubMed
27.
go back to reference Jozkowicz A, Nigisch A, Wegrzyn J, Weigel G, Huk I, Dulak J (2004) Opposite effects of prostaglandin-J2 on VEGF in normoxia and hypoxia: role of HIF-1. Biochem Biophys Res Commun 314:31–38CrossRefPubMed Jozkowicz A, Nigisch A, Wegrzyn J, Weigel G, Huk I, Dulak J (2004) Opposite effects of prostaglandin-J2 on VEGF in normoxia and hypoxia: role of HIF-1. Biochem Biophys Res Commun 314:31–38CrossRefPubMed
28.
go back to reference Shan ZZ, Masuko-Hongo K, Dai SM, Nakamura H, Kato T, Nishioka K (2004) A potential role of 15-deoxy-delta(12,14)-prostaglandin J2 for induction of human articular chondrocyte apoptosis in arthritis. J Biol Chem 279:37939–37950CrossRefPubMed Shan ZZ, Masuko-Hongo K, Dai SM, Nakamura H, Kato T, Nishioka K (2004) A potential role of 15-deoxy-delta(12,14)-prostaglandin J2 for induction of human articular chondrocyte apoptosis in arthritis. J Biol Chem 279:37939–37950CrossRefPubMed
29.
go back to reference Tornblom N, Malers E, Wallenius G (1959) Osteodermatopathia hypertrophicans. Acta Med Scand 164:325–339CrossRefPubMed Tornblom N, Malers E, Wallenius G (1959) Osteodermatopathia hypertrophicans. Acta Med Scand 164:325–339CrossRefPubMed
31.
go back to reference Kennedy CR, Xiong H, Rahal S, Vanderluit J, Slack RS, Zhang Y, Guan Y, Breyer MD, Hébert RL (2007) Urine concentrating defect in prostaglandin EP1-deficient mice. Am J Physiol Renal Physiol 292:F868–F875CrossRefPubMed Kennedy CR, Xiong H, Rahal S, Vanderluit J, Slack RS, Zhang Y, Guan Y, Breyer MD, Hébert RL (2007) Urine concentrating defect in prostaglandin EP1-deficient mice. Am J Physiol Renal Physiol 292:F868–F875CrossRefPubMed
32.
go back to reference Morimoto K, Shirata N, Taketomi Y, Tsuchiya S, Segi-Nishida E, Inazumi T, Kabashima K, Tanaka S, Murakami M, Narumiya S, Sugimoto Y (2014) Prostaglandin E2-EP3 signaling induces inflammatory swelling by mast cell activation. J Immunol 192:1130–1137CrossRefPubMed Morimoto K, Shirata N, Taketomi Y, Tsuchiya S, Segi-Nishida E, Inazumi T, Kabashima K, Tanaka S, Murakami M, Narumiya S, Sugimoto Y (2014) Prostaglandin E2-EP3 signaling induces inflammatory swelling by mast cell activation. J Immunol 192:1130–1137CrossRefPubMed
33.
go back to reference Crump C (1929) Histologie der allgemeinen Osteophytose. (Osteoarthropathie hypertrophiante pneumique). Virchows Arch 271:467–511CrossRef Crump C (1929) Histologie der allgemeinen Osteophytose. (Osteoarthropathie hypertrophiante pneumique). Virchows Arch 271:467–511CrossRef
34.
go back to reference Brunner W (1967) <<Subakute Polyarthritis>> bei Bronchuskarzinom - ein paraneoplastisches Syndrom. Schweiz Med Wochenschr 97:611–612PubMed Brunner W (1967) <<Subakute Polyarthritis>> bei Bronchuskarzinom - ein paraneoplastisches Syndrom. Schweiz Med Wochenschr 97:611–612PubMed
35.
go back to reference Rodemann HP, Goldberg AL (1982) Arachidonic acid, prostaglandin E2 and F2 alpha influence rates of protein turnover in skeletal and cardiac muscle. J Biol Chem 257:1632–1638PubMed Rodemann HP, Goldberg AL (1982) Arachidonic acid, prostaglandin E2 and F2 alpha influence rates of protein turnover in skeletal and cardiac muscle. J Biol Chem 257:1632–1638PubMed
36.
go back to reference Joh K, Riede UN, Zahradnik HP (1983) The effect of prostaglandins on the lysosomal function in the cervix uteri. Arch Gynecol 234:1–16CrossRefPubMed Joh K, Riede UN, Zahradnik HP (1983) The effect of prostaglandins on the lysosomal function in the cervix uteri. Arch Gynecol 234:1–16CrossRefPubMed
37.
go back to reference Singh J, Verma NK, Kansagra SM, Kate BN, Dey CS (2007) Altered PPARgamma expression inhibits myogenic differentiation in C2C12 skeletal muscle cells. Mol Cell Biochem 294:163–171CrossRefPubMed Singh J, Verma NK, Kansagra SM, Kate BN, Dey CS (2007) Altered PPARgamma expression inhibits myogenic differentiation in C2C12 skeletal muscle cells. Mol Cell Biochem 294:163–171CrossRefPubMed
39.
go back to reference Jao JY, Barlow JJ, Krant MJ (1969) Pulmonary hypertrophic osteoarthropathy, spider angiomata, and estrogen hyperexcretion in neoplasia. Ann Intern Med 70:581–584CrossRefPubMed Jao JY, Barlow JJ, Krant MJ (1969) Pulmonary hypertrophic osteoarthropathy, spider angiomata, and estrogen hyperexcretion in neoplasia. Ann Intern Med 70:581–584CrossRefPubMed
40.
go back to reference Martini GA (1975) Extrahepatic manifestations of cirrhosis. Clin Gastroenterol 4:439–460PubMed Martini GA (1975) Extrahepatic manifestations of cirrhosis. Clin Gastroenterol 4:439–460PubMed
41.
go back to reference Hedge GA (1977) Roles for the prostaglandins in the regulation of anterior pituitary secretion. Life Sci 20:17–33CrossRefPubMed Hedge GA (1977) Roles for the prostaglandins in the regulation of anterior pituitary secretion. Life Sci 20:17–33CrossRefPubMed
42.
go back to reference Nguyen M, Camenisch T, Snouwaert JN, Hicks E, Coffman TM, Anderson PA, Malouf NN, Koller BH (1997) The prostaglandin receptor EP4 triggers remodelling of the cardiovascular system at birth. Nature 390:78–81CrossRefPubMed Nguyen M, Camenisch T, Snouwaert JN, Hicks E, Coffman TM, Anderson PA, Malouf NN, Koller BH (1997) The prostaglandin receptor EP4 triggers remodelling of the cardiovascular system at birth. Nature 390:78–81CrossRefPubMed
43.
go back to reference Hoevels-Guerich H, Haferkorn L, Persigehl M, Hofstetter R, von Bernuth G (1984) Widening of cranial sutures after long-term prostaglandin E2 therapy in two newborn infants. J Pediatr 105:72–74CrossRefPubMed Hoevels-Guerich H, Haferkorn L, Persigehl M, Hofstetter R, von Bernuth G (1984) Widening of cranial sutures after long-term prostaglandin E2 therapy in two newborn infants. J Pediatr 105:72–74CrossRefPubMed
44.
go back to reference Iwata C, Akimoto N, Sato T, Morokuma Y, Ito A (2005) Augmentation of lipogenesis by 15-deoxy-Delta12,14-prostaglandin J2 in hamster sebaceous glands: identification of cytochrome P-450-mediated 15-deoxy-Delta12,14-prostaglandin J2 production. J Invest Dermatol 125:865–872CrossRefPubMed Iwata C, Akimoto N, Sato T, Morokuma Y, Ito A (2005) Augmentation of lipogenesis by 15-deoxy-Delta12,14-prostaglandin J2 in hamster sebaceous glands: identification of cytochrome P-450-mediated 15-deoxy-Delta12,14-prostaglandin J2 production. J Invest Dermatol 125:865–872CrossRefPubMed
45.
go back to reference Boyd EJ, Hulks G, Thomas JS, McColl KE (1988) Hypertrophic gastritis associated with increased gastric mucosal prostaglandin E2 concentrations in a patient with the carcinoid syndrome. Gut 29:1270–1276CrossRefPubMedCentralPubMed Boyd EJ, Hulks G, Thomas JS, McColl KE (1988) Hypertrophic gastritis associated with increased gastric mucosal prostaglandin E2 concentrations in a patient with the carcinoid syndrome. Gut 29:1270–1276CrossRefPubMedCentralPubMed
46.
go back to reference Fontenay-Roupie M, Dupuy E, Berrou E, Tobelem G, Bryckaert M (1995) Increased proliferation of bone marrow-derived fibroblasts in primitive hypertrophic osteoarthropathy with severe myelofibrosis. Blood 85:3229–3238PubMed Fontenay-Roupie M, Dupuy E, Berrou E, Tobelem G, Bryckaert M (1995) Increased proliferation of bone marrow-derived fibroblasts in primitive hypertrophic osteoarthropathy with severe myelofibrosis. Blood 85:3229–3238PubMed
47.
go back to reference Erl W, Weber C, Zernecke A, Neuzil J, Vosseler CA, Kim HJ, Weber PC (2004) Cyclopentenone prostaglandins induce endothelial cell apoptosis independent of the peroxisome proliferator-activated receptor-gamma. Eur J Immunol 34:241–250CrossRefPubMed Erl W, Weber C, Zernecke A, Neuzil J, Vosseler CA, Kim HJ, Weber PC (2004) Cyclopentenone prostaglandins induce endothelial cell apoptosis independent of the peroxisome proliferator-activated receptor-gamma. Eur J Immunol 34:241–250CrossRefPubMed
48.
go back to reference Destouet JM, Murphy WA (1983) Acquired acroosteolysis and acronecrosis. Arthritis Rheum 26:1150–1154CrossRefPubMed Destouet JM, Murphy WA (1983) Acquired acroosteolysis and acronecrosis. Arthritis Rheum 26:1150–1154CrossRefPubMed
49.
go back to reference Materazzi S, Nassini R, Andrè E, Campi B, Amadesi S, Trevisani M, Bunnett NW, Patacchini R, Geppetti P (2008) Cox-dependent fatty acid metabolites cause pain through activation of the irritant receptor TRPA1. Proc Natl Acad Sci U S A 105:12045–12050CrossRefPubMedCentralPubMed Materazzi S, Nassini R, Andrè E, Campi B, Amadesi S, Trevisani M, Bunnett NW, Patacchini R, Geppetti P (2008) Cox-dependent fatty acid metabolites cause pain through activation of the irritant receptor TRPA1. Proc Natl Acad Sci U S A 105:12045–12050CrossRefPubMedCentralPubMed
50.
go back to reference Andersson DA, Gentry C, Alenmyr L, et al. TRPA1 mediates spinal antinociception induced by acetaminophen and the cannabinoid Delta(9)-tetrahydrocannabiorcol. Nat Commun 2:551 Andersson DA, Gentry C, Alenmyr L, et al. TRPA1 mediates spinal antinociception induced by acetaminophen and the cannabinoid Delta(9)-tetrahydrocannabiorcol. Nat Commun 2:551
Metadata
Title
Hypertrophic osteoarthropathy: estrogens, prostaglandinE2, prostaglandin A2, and the inflammatory reflex
Authors
Ad Brouwers
Pieter G. Dingjan
Ben Dujardin
Everardus J. van Zoelen
Paul Lips
Louis J. Gooren
Publication date
01-01-2019
Publisher
Springer London
Published in
Clinical Rheumatology / Issue 1/2019
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-018-4044-z

Other articles of this Issue 1/2019

Clinical Rheumatology 1/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.